08
Oct

Rescued from Pfizer’s sweeping R&D cuts, Levicept’s lead drug is a protein with promise in chronic pain, and the biotech has raised $15.7 million in venture and grant funding to follow through on its potential.

…read more

Source: Levicept emerges from Pfizer’s R&D ashes with $20M and a new pain drug

    

0 No comments